Oxford Asset Management’s OptimizeRx OPRX Stock Holding History

Oxford Asset Management’s Portfolio OPRX Stock Details OPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-39,024	Closed	-$245K	–	548
2026 Q1	$245K	Buy	+39,024	New	+$362K	0.1%	313
2019 Q3	–	Sell	-14,275	Closed	-$231K	–	1888
2019 Q2	$231K	Buy	+14,275	New	+$193K	0.01%	1520
2019 Q1	–	Sell	-30,231	Closed	-$332K	–	1889
2018 Q4	$332K	Buy	+30,231	New	+$447K	0.01%	1363

Other funds holding OPRX

WCA

Whetstone Capital Advisors Shawnee Mission, Kansas $380M AUM 20.01% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

KCM

Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return

Oxford Asset Management's OPRX Position: Q2 2026 in Review

Oxford Asset Management sold out of OptimizeRx (OPRX) in Q2 2026, closing a stake of 39,024 shares — an estimated $245K sold.

Oxford Asset Management first reported a position in OPRX in Q4 2018 and held it in 3 quarters. The position peaked at $332K in Q4 2018. 113 funds tracked by Wall St. Rank hold OPRX as of Q2 2026.

Oxford Asset Management reported no remaining OptimizeRx position as of Q2 2026 after selling out during the quarter.
Oxford Asset Management sold 39,024 OptimizeRx shares in Q2 2026, an estimated $245K.
Oxford Asset Management first reported a position in OptimizeRx in Q4 2018 and held it in 3 quarters.
Oxford Asset Management's OptimizeRx position peaked at $332K in Q4 2018.
113 funds tracked by Wall St. Rank held OptimizeRx as of Q2 2026.

Based on Oxford Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.